Developing Safer Medications for Pain and Inflammation

Sponsored Post:
At nearly 70, a lot of people deal with excruciating pain. It’s not easy, nor is it comforting to watch those struggle just to move. Unfortunately, there are millions more just like people experiencing arthritic pain. It has been said that approximately 23% of people in the US have arthritis, according to the US Centers for Disease Control and Prevention (CDC). Unfortunately, about 24 million persons with extreme joint pain records have restricted movements. (1) Wanna join your loved ones for a walk without potentially experiencing arthritic pain? Come on and let’s find out!

Due to deprivation of productivity, arthritic pain poses a great economic and health burden. Non-steroidal anti-inflammatory drugs are primarily used for treatments of pain and inflammation. To potentially treat it, millions turn to NSAIDs or non-steroidal anti-inflammatory drugs. In fact, roughly 84 million NSAID prescriptions are being written every year in the US, according to fortune market insights. (2) Do you want to know more promising effect of NSAID? You better watch this one!

No one should experience dealing with arthritic pain. That’s why these therapeutic industries are here to develop next-generation safer therapies to address inflammation taken from a wide range of medical conditions. The current pipeline includes three assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs. Additional assets under development include a safer alternative to opioids for perioperative pain and a gastrointestinal-protective alternative to low-dose aspirin. The next target is inflammatory bowel disease. For a condition long in need of safer, more effective therapies, continue exploring here and you might know potential information about it! Check the disclaimer on my profile

Source 1: https://www.cdc.gov/chronicdisease/resources/publications/factsheets/arthritis.htm
Source 2: https://bit.ly/31TOyw5